Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
McDonald's
MCD
|
$816M |
| 2 |
Crown Castle
CCI
|
$691M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$581M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$467M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$304M |
Top Sells
| 1 |
Nike
NKE
|
$1.34B |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.09B |
| 3 |
Amazon
AMZN
|
$671M |
| 4 |
TWX
Time Warner Inc
TWX
|
$463M |
| 5 |
NXP Semiconductors
NXPI
|
$452M |
Sector Composition
| 1 | Technology | 20.95% |
| 2 | Consumer Discretionary | 17.67% |
| 3 | Healthcare | 13.89% |
| 4 | Communication Services | 13.06% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Exact Sciences
EXAS
$10.2B
| $5.1M | 0.01% |
144,245
+123,618
| +599% | +$4.37M |
|
502
Tile Shop Holdings
TTSH
$282M
| $4.86M | 0.01% |
+235,366
| New | +$4.86M |
|
503
iRhythm Technologies
IRTC
$6.01B
| $4.07M | ﹤0.01% |
95,741
-830
| -0.9% | -$35.3K |
|
504
Hess Midstream
HESM
$5.25B
| $4.06M | ﹤0.01% |
+199,099
| New | +$4.06M |
|
505
Omega Healthcare
OHI
$12.8B
| $3.61M | ﹤0.01% |
109,246
+22,493
| +26% | +$743K |
|
506
Exxon Mobil
XOM
$468B
| $3.58M | ﹤0.01% |
44,315
-701
| -2% | -$56.6K |
|
507
Johnson & Johnson
JNJ
$429B
| $3.54M | ﹤0.01% |
26,750
+5
| +0% | +$661 |
|
508
Berkshire Hathaway Class B
BRK.B
$1.07T
| $3.45M | ﹤0.01% |
20,385
+80
| +0.4% | +$13.6K |
|
509
Baxter International
BAX
$12.4B
| $3.44M | ﹤0.01% |
56,818
+25,905
| +84% | +$1.57M |
|
510
Tempest Therapeutics
TPST
$48.2M
| $3.42M | ﹤0.01% |
749
+2
| +0.3% | +$9.13K |
|
511
Waste Management
WM
$88.2B
| $3.38M | ﹤0.01% |
46,046
-96,462
| -68% | -$7.07M |
|
512
Emerson Electric
EMR
$74.7B
| $3.37M | ﹤0.01% |
56,586
+6,379
| +13% | +$380K |
|
|
XL
513
DELISTED
XL Group Ltd.
XL
| $3.37M | ﹤0.01% |
76,862
-3,044
| -4% | -$133K |
|
514
MacroGenics
MGNX
$111M
| $3.33M | ﹤0.01% |
189,970
+1,062
| +0.6% | +$18.6K |
|
515
APA Corp
APA
$7.96B
| $3.2M | ﹤0.01% |
66,809
+51,286
| +330% | +$2.46M |
|
516
UroGen Pharma
URGN
$991M
| $3.17M | ﹤0.01% |
+175,410
| New | +$3.17M |
|
517
SPDR S&P Metals & Mining ETF
XME
$2.35B
| $3.05M | ﹤0.01% |
101,796
-6,526
| -6% | -$196K |
|
518
Elevance Health
ELV
$69.4B
| $2.82M | ﹤0.01% |
15,005
-2,567
| -15% | -$483K |
|
|
RNTX
519
Rein Therapeutics, Inc. Common Stock
RNTX
$31.2M
| $2.79M | ﹤0.01% |
+12,500
| New | +$2.79M |
|
520
argenx
ARGX
$47B
| $2.66M | ﹤0.01% |
+125,285
| New | +$2.66M |
|
521
LyondellBasell Industries
LYB
$17.6B
| $2.49M | ﹤0.01% |
29,461
+22,865
| +347% | +$1.93M |
|
522
Webster Financial
WBS
$10.3B
| $2.47M | ﹤0.01% |
47,275
+3,504
| +8% | +$183K |
|
|
RTN
523
DELISTED
Raytheon Company
RTN
| $2.46M | ﹤0.01% |
15,243
+532
| +4% | +$85.9K |
|
|
NAK
524
Northern Dynasty Minerals
NAK
$454M
| $2.45M | ﹤0.01% |
1,763,422
| – | – |
|
525
Tyson Foods
TSN
$19.9B
| $2.44M | ﹤0.01% |
39,008
+1,760
| +5% | +$110K |
|